Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

ShangPharma Forms Drug Translation Collaboration with UCSF

publication date: Jul 14, 2017
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
ShangPharma Innovation, Inc. (SPII) will collaborate with the University of California San Francisco by providing UCSF scientists with funding and other support to accelerate the development of promising life science discoveries. ShangPharma plans to bring industrial development to UCSF's academic projects. SPII agreed to provide "several years of funding" to underwrite R&D in UCSF labs. It will also pay for CRO services at ChemPartner for joint SPII-UCSF projects. SPII and UCSF will own the projects jointly, though no further financial details were provided. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...